English

Prenatal Stress Detection from Electrocardiography Using Self-Supervised Deep Learning: Development and External Validation

Quantitative Methods 2026-04-28 v3 Machine Learning

Abstract

Prenatal psychological stress affects 15-25% of pregnancies and increases risks of preterm birth, low birth weight, and adverse neurodevelopmental outcomes. Current screening relies on subjective questionnaires (PSS-10), limiting continuous monitoring. We developed deep learning models for stress detection from electrocardiography (ECG) using the FELICITy 1 cohort (151 pregnant women, 32-38 weeks gestation). A ResNet-34 encoder was pretrained via SimCLR contrastive learning on 40,692 ECG segments per subject. Multi-layer feature extraction enabled binary classification and continuous PSS prediction across maternal (mECG), fetal (fECG), and abdominal ECG (aECG). External validation used the FELICITy 2 RCT (28 subjects, different ECG device, yoga intervention vs. control). On FELICITy 1 (5-fold CV): mECG 98.6% accuracy (R2=0.88, MAE=1.90), fECG 99.8% (R2=0.95, MAE=1.19), aECG 95.5% (R2=0.75, MAE=2.80). External validation on FELICITy 2: mECG 77.3% accuracy (R2=0.62, MAE=3.54, AUC=0.826), aECG 63.6% (R2=0.29, AUC=0.705). Signal quality-based channel selection outperformed all-channel averaging (+12% R2 improvement). Mixed-effects models detected a significant intervention response (p=0.041). Self-supervised deep learning on pregnancy ECG enables accurate, objective stress assessment, with multi-layer feature extraction substantially outperforming single embedding approaches.

Keywords

Cite

@article{arxiv.2602.03886,
  title  = {Prenatal Stress Detection from Electrocardiography Using Self-Supervised Deep Learning: Development and External Validation},
  author = {Martin G. Frasch and Marlene J. E. Mayer and Clara Becker and Peter Zimmermann and Camilla Zelgert and Marta C. Antonelli and Silvia M. Lobmaier},
  journal= {arXiv preprint arXiv:2602.03886},
  year   = {2026}
}

Comments

22 pages, 5 figures. A patent was filed by JoyBeat Medical, Inc, for the technology described (US Patent Application No.63/968,084)

R2 v1 2026-07-01T09:34:52.281Z